News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Novo Nordisk A/S’s Novoeight Wins FDA Approval for Hemophilia A
October 16, 2013
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Denmark's Novo Nordisk has received a licence application approval in the United States for its haemophilia drug Novoeight.
Help employers find you! Check out all the
jobs
and
post your resume
.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Europe
Food and Drug Administration (FDA)
Novo Nordisk
MORE ON THIS TOPIC
FDA
FDA Provides Guidance To Prevent Returned Applications, Aid Patient-Focused Drug Development
October 24, 2025
·
2 min read
·
Tristan Manalac
Approvals
GSK’s Blenrep Makes Comeback With FDA Nod for Third-Line Multiple Myeloma
October 24, 2025
·
2 min read
·
Tristan Manalac
Podcast
Novo Board Upended, ESMO Excitement, FDA Awards, Replimune’s U-Turn
October 22, 2025
·
1 min read
·
Heather McKenzie
FDA
Krystal Biotech’s FDA Platform Designation Pushes Limits of the Award
October 21, 2025
·
2 min read
·
Dan Samorodnitsky